Humulin R, Regular, insulin human injection, USP, recombinant DNA origin

Description (Brief)
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases. Developed by Genentech, the first American biotechnology company, Humulin was licensed to Eli Lilly and became the first marketable product created through recombinant DNA technology. Its licensing by the FDA in October 1982 also made it the first recombinant pharmaceutical approved for use in the United States.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human insulin are inserted into bacteria. Bacteria produce insulin, which is harvested and used as the active ingredient in Humulin.
Humulin R is considered to be "regular" insulin and has had nothing added to change the speed or length of its action. It takes effect rapidly and has a relatively short duration of activity (6 to 8 hours) as compared with other insulin formulations.
Object consists of a white cardboard box with black and red printing. Box contains two product inserts and one round clear glass bottle with an orange plastic cap and a white label. Bottle contains a yellowish, clear solution.
Location
Currently not on view
Object Name
humulin
biological, human insulin
pharmaceutical
biological
human insulin
date made
1987
maker
Eli Lilly and Company
Physical Description
human insulin (drug active ingredients)
cardboard (container material)
paper (container material)
glass (container material)
Measurements
overall: 2 3/4 in x 1 5/16 in x 1 5/16 in; 6.985 cm x 3.33375 cm x 3.33375 cm
place made
United States: Indiana, Indianapolis
ID Number
1987.0790.03
accession number
1987.0790
catalog number
1987.0790.03
subject
Recombinant Pharmaceuticals
Biotechnology and Genetics
Health & Medicine
Science & Mathematics
Diabetes
See more items in
Medicine and Science: Medicine
Recombinant Pharmaceuticals
Biotechnology and Genetics
Diabetes
Data Source
National Museum of American History, Kenneth E. Behring Center
Credit Line
Eli Lilly and Company (through Carol Edgar)
Additional Media

Visitor Comments

Add a comment about this object

Submit a comment or ask a question about this object using the form below. Submissions are moderated and may receive a curator response. Please note that we cannot evaluate or appraise your personal artifacts. For other questions or general inquiries please visit our FAQ or contact page.

Personal information will not be shared or result in unsolicited e-mail. See our privacy policy.

Image CAPTCHA
Enter the characters shown in the image.